Global Edaravone Injection Market Research Report 2020
SKU ID : QYR-15124947 | Publishing Date : 24-Jan-2020 | No. of pages : 97
Detailed TOC of Global Edaravone Injection Market Research Report 2020
Table of Contents1 Edaravone Injection Market Overview
1.1 Product Overview and Scope of Edaravone Injection
1.2 Edaravone Injection Segment by Type
1.2.1 Global Edaravone Injection Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 20ml
1.2.3 100ml
1.3 Edaravone Injection Segment by Application
1.3.1 Edaravone Injection Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Edaravone Injection Market Size Estimates and Forecasts
1.4.1 Global Edaravone Injection Revenue 2015-2026
1.4.2 Global Edaravone Injection Sales 2015-2026
1.4.3 Edaravone Injection Market Size by Region: 2020 Versus 2026
2 Global Edaravone Injection Market Competition by Manufacturers
2.1 Global Edaravone Injection Sales Market Share by Manufacturers (2015-2020)
2.2 Global Edaravone Injection Revenue Share by Manufacturers (2015-2020)
2.3 Global Edaravone Injection Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Edaravone Injection Manufacturing Sites, Area Served, Product Type
2.5 Edaravone Injection Market Competitive Situation and Trends
2.5.1 Edaravone Injection Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Edaravone Injection Players (Opinion Leaders)
3 Edaravone Injection Retrospective Market Scenario by Region
3.1 Global Edaravone Injection Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Edaravone Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Edaravone Injection Market Facts & Figures by Country
3.3.1 North America Edaravone Injection Sales by Country
3.3.2 North America Edaravone Injection Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Edaravone Injection Market Facts & Figures by Country
3.4.1 Europe Edaravone Injection Sales by Country
3.4.2 Europe Edaravone Injection Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Edaravone Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Edaravone Injection Sales by Region
3.5.2 Asia Pacific Edaravone Injection Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Edaravone Injection Market Facts & Figures by Country
3.6.1 Latin America Edaravone Injection Sales by Country
3.6.2 Latin America Edaravone Injection Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Edaravone Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Edaravone Injection Sales by Country
3.7.2 Middle East and Africa Edaravone Injection Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Edaravone Injection Historic Market Analysis by Type
4.1 Global Edaravone Injection Sales Market Share by Type (2015-2020)
4.2 Global Edaravone Injection Revenue Market Share by Type (2015-2020)
4.3 Global Edaravone Injection Price Market Share by Type (2015-2020)
4.4 Global Edaravone Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Edaravone Injection Historic Market Analysis by Application
5.1 Global Edaravone Injection Sales Market Share by Application (2015-2020)
5.2 Global Edaravone Injection Revenue Market Share by Application (2015-2020)
5.3 Global Edaravone Injection Price by Application (2015-2020)
6 Company Profiles and Key Figures in Edaravone Injection Business
6.1 Mitsubishi Tanabe Pharma
6.1.1 Corporation Information
6.1.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
6.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Mitsubishi Tanabe Pharma Products Offered
6.1.5 Mitsubishi Tanabe Pharma Recent Development
7 Edaravone Injection Manufacturing Cost Analysis
7.1 Edaravone Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Edaravone Injection
7.4 Edaravone Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Edaravone Injection Distributors List
8.3 Edaravone Injection Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Edaravone Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Edaravone Injection by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Edaravone Injection by Type (2021-2026)
10.2 Edaravone Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Edaravone Injection by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Edaravone Injection by Application (2021-2026)
10.3 Edaravone Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Edaravone Injection by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Edaravone Injection by Region (2021-2026)
10.4 North America Edaravone Injection Estimates and Projections (2021-2026)
10.5 Europe Edaravone Injection Estimates and Projections (2021-2026)
10.6 Asia Pacific Edaravone Injection Estimates and Projections (2021-2026)
10.7 Latin America Edaravone Injection Estimates and Projections (2021-2026)
10.8 Middle East and Africa Edaravone Injection Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Edaravone Injection Market Research Report 2020
List of TablesTable 1. Global Edaravone Injection Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Edaravone Injection Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Edaravone Injection Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Edaravone Injection Manufacturers Covered in This Study
Table 5. Global Edaravone Injection Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Edaravone Injection Sales Share by Manufacturers (2015-2020)
Table 7. Global Edaravone Injection Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Edaravone Injection Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Edaravone Injection Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Edaravone Injection Sales Sites and Area Served
Table 11. Manufacturers Edaravone Injection Product Types
Table 12. Global Edaravone Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Edaravone Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Edaravone Injection as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Edaravone Injection Players
Table 16. Global Edaravone Injection Sales (K MT) by Region (2015-2020)
Table 17. Global Edaravone Injection Sales Market Share by Region (2015-2020)
Table 18. Global Edaravone Injection Revenue (Million US$) by Region (2015-2020)
Table 19. Global Edaravone Injection Revenue Market Share by Region (2015-2020)
Table 20. North America Edaravone Injection Sales by Country (2015-2020) (K MT)
Table 21. North America Edaravone Injection Sales Market Share by Country (2015-2020)
Table 22. North America Edaravone Injection Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Edaravone Injection Revenue Market Share by Country (2015-2020)
Table 24. Europe Edaravone Injection Sales by Country (2015-2020) (K MT)
Table 25. Europe Edaravone Injection Sales Market Share by Country (2015-2020)
Table 26. Europe Edaravone Injection Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Edaravone Injection Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Edaravone Injection Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Edaravone Injection Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Edaravone Injection Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Edaravone Injection Revenue Market Share by Region (2015-2020)
Table 32. Latin America Edaravone Injection Sales by Country (2015-2020) (K MT)
Table 33. Latin America Edaravone Injection Sales Market Share by Country (2015-2020)
Table 34. Latin America Edaravone Injection Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Edaravone Injection Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Edaravone Injection Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Edaravone Injection Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Edaravone Injection Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Edaravone Injection Revenue Market Share by Country (2015-2020)
Table 40. Global Edaravone Injection Sales (K MT) by Type (2015-2020)
Table 41. Global Edaravone Injection Sales Share by Type (2015-2020)
Table 42. Global Edaravone Injection Revenue (Million US$) by Type (2015-2020)
Table 43. Global Edaravone Injection Revenue Share by Type (2015-2020)
Table 44. Global Edaravone Injection Price (USD/MT) by Type (2015-2020)
Table 45. Global Edaravone Injection Sales (K MT) by Application (2015-2020)
Table 46. Global Edaravone Injection Sales Market Share by Application (2015-2020)
Table 47. Global Edaravone Injection Sales Growth Rate by Application (2015-2020)
Table 48. Mitsubishi Tanabe Pharma Edaravone Injection Corporation Information
Table 49. Mitsubishi Tanabe Pharma Description and Business Overview
Table 50. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Mitsubishi Tanabe Pharma Main Product
Table 52. Mitsubishi Tanabe Pharma Recent Development
Table 53. Sales Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Edaravone Injection Distributors List
Table 56. Edaravone Injection Customers List
Table 57. Market Key Trends
Table 58. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 59. Key Challenges
Table 60. Global Edaravone Injection Sales (K MT) Forecast by Type (2021-2026)
Table 61. Global Edaravone Injection Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Edaravone Injection Revenue (Million US$) Forecast by Type (2021-2026)
Table 63. Global Edaravone Injection Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 64. Global Edaravone Injection Sales (K MT) Forecast by Application (2021-2026)
Table 65. Global Edaravone Injection Revenue (Million US$) Forecast by Application (2021-2026)
Table 66. Global Edaravone Injection Sales (K MT) Forecast by Region (2021-2026)
Table 67. Global Edaravone Injection Sales Market Share Forecast by Region (2021-2026)
Table 68. Global Edaravone Injection Revenue Forecast by Region (2021-2026) (US$ Million)
Table 69. Global Edaravone Injection Revenue Market Share Forecast by Region (2021-2026)
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Edaravone Injection
Figure 2. Global Edaravone Injection Sales Market Share by Type: 2020 VS 2026
Figure 3. 20ml Product Picture
Figure 4. 100ml Product Picture
Figure 5. Global Edaravone Injection Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Edaravone Injection Market Size 2015-2026 (US$ Million)
Figure 9. Global Edaravone Injection Sales Capacity (K MT) (2015-2026)
Figure 10. Global Edaravone Injection Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Edaravone Injection Sales Share by Manufacturers in 2020
Figure 12. Global Edaravone Injection Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Edaravone Injection Revenue in 2019
Figure 14. Edaravone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Edaravone Injection Sales Market Share by Region (2015-2020)
Figure 16. Global Edaravone Injection Sales Market Share by Region in 2019
Figure 17. Global Edaravone Injection Revenue Market Share by Region (2015-2020)
Figure 18. Global Edaravone Injection Revenue Market Share by Region in 2019
Figure 19. North America Edaravone Injection Sales Market Share by Country in 2019
Figure 20. North America Edaravone Injection Revenue Market Share by Country in 2019
Figure 21. U.S. Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 22. U.S. Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 24. Canada Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Edaravone Injection Sales Market Share by Country in 2019
Figure 26. Europe Edaravone Injection Revenue Market Share by Country in 2019
Figure 27. Germany Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 28. Germany Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 30. France Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 32. U.K. Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 34. Italy Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 36. Russia Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Edaravone Injection Sales Market Share by Region in 2019
Figure 38. Asia Pacific Edaravone Injection Revenue Market Share by Region in 2019
Figure 39. China Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 40. China Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 42. Japan Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 44. South Korea Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 46. India Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 48. Australia Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 50. Taiwan Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 52. Indonesia Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 54. Thailand Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 56. Malaysia Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 58. Philippines Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 60. Vietnam Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Edaravone Injection Sales Market Share by Country in 2019
Figure 62. Latin America Edaravone Injection Revenue Market Share by Country in 2019
Figure 63. Mexico Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 64. Mexico Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 66. Brazil Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 68. Argentina Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Edaravone Injection Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Edaravone Injection Revenue Market Share by Country in 2019
Figure 71. Turkey Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 72. Turkey Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 74. Saudi Arabia Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Edaravone Injection Sales Growth Rate (2015-2020) (K MT)
Figure 76. U.A.E Edaravone Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Edaravone Injection by Type (2015-2020)
Figure 78. Sales Market Share of Edaravone Injection by Type in 2019
Figure 79. Revenue Share of Edaravone Injection by Type (2015-2020)
Figure 80. Revenue Market Share of Edaravone Injection by Type in 2019
Figure 81. Global Edaravone Injection Sales Growth by Type (2015-2020) (K MT)
Figure 82. Global Edaravone Injection Sales Market Share by Application (2015-2020)
Figure 83. Global Edaravone Injection Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Edaravone Injection by Application (2015-2020)
Figure 85. Global Revenue Share of Edaravone Injection by Application in 2020
Figure 86. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Price Trend of Key Raw Materials
Figure 88. Manufacturing Cost Structure of Edaravone Injection
Figure 89. Manufacturing Process Analysis of Edaravone Injection
Figure 90. Edaravone Injection Industrial Chain Analysis
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Porter's Five Forces Analysis
Figure 94. North America Edaravone Injection Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 95. North America Edaravone Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 96. Europe Edaravone Injection Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 97. Europe Edaravone Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 98. Latin America Edaravone Injection Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 99. Latin America Edaravone Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 100. Middle East and Africa Edaravone Injection Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 101. Middle East and Africa Edaravone Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Asia Pacific Edaravone Injection Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 103. Asia Pacific Edaravone Injection Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed